X

Trial Profile

Phase I trial of insulin-coated gold nanoparticles administered in a transbuccal film to healthy volunteers.

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 12 Jun 2023

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Insulin (Primary)
Indications Diabetes mellitus
Focus Adverse reactions; Pharmacokinetics

Most Recent Events

16 May 2023 According to Biodexa Pharmaceuticals, 20-F filing, Midatech has changed its name to Biodexa Pharmaceuticals
30 Nov 2017 According to a Aquestive Therapeutics media release, MonoSol Rx changed its name to Aquestive Therapeutics
03 May 2012 Top-line results will be presented at the European Summit for Clinical Nanomedicine (CLINAM) in 2012 as reported by Midatech and Monosol Rx.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com